Regeneron Pharmaceuticals reported solid Q4 sales, but the big cap biotech’s stock reversed lower Tuesday as its potentially huge new cholesterol fighter was in the crosshairs of a leading pharmacy benefit manager (PBM). At the JPMorgan Healthcare Conference in San Francisco, Express Scripts (ESRX) CEO George Paz chatted at a Q&A session about his company’s recent success at driving discounts to pricey new hepatitis C drugs by
Cancer therapies and bullish earnings forecasts took the spotlight Monday at the opening of JPMorgan’s Healthcare Conference this week in San Francisco, one of the largest annual biotech conferences worldwide. Celgene (CELG) provided a bullish forecast for its cancer drug Revlimid, along with generally positive preliminary Q4 results and long-term financial outlook. Bristol-Myers Squibb (BMY) announced positive-trial results for
BitAuto stock rose for a sixth straight session, climbing Friday on news that the Chinese car information website operator will receive $1.3 billion from No. 2 China online retailer JD.com and China Web giant Tencent Holdings. Tencent (TCEHY) — best known for communications app WeChat — and JD.com (JD) also will invest a combined $250 million in BitAuto’s e-commerce auto-financing unit, YiXin Capital. Tencent owns a 15%